检索结果 - Klearman, Micki

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial

    Development and Implementation of a Double-Blind Corticosteroid-Tapering Regimen for a Clinical Trial 由 Collinson, Neil, Tuckwell, Katie, Habeck, Frank, Chapman, Monique, Klearman, Micki, Stone, John H.

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  2. 2
    Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)

    Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA) 由 Bingham, Clifton O, Rizzo, Warren, Kivitz, Alan, Hassanali, Azra, Upmanyu, Ruchi, Klearman, Micki

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  3. 3
    Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial

    Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial 由 Strand, Vibeke, Dimonaco, Sophie, Tuckwell, Katie, Klearman, Micki, Collinson, Neil, Stone, John H.

    出版 2019
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  4. 4
    Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

    Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis 由 Gabay, Cem, McInnes, Iain B, Kavanaugh, Arthur, Tuckwell, Katie, Klearman, Micki, Pulley, Jennifer, Sattar, Naveed

    出版 2016
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  5. 5
    Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study

    Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study 由 Kim, Seoyoung C., Solomon, Daniel H., Rogers, James R., Gale, Sara, Klearman, Micki, Sarsour, Khaled, Schneeweiss, Sebastian

    出版 2017
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab

    Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab 由 Stone, John H., Tuckwell, Katie, Dimonaco, Sophie, Klearman, Micki, Aringer, Martin, Blockmans, Daniel, Brouwer, Elisabeth, Cid, Maria C., Dasgupta, Bhaskar, Rech, Juergen, Salvarani, Carlo, Schulze‐Koops, Hendrik, Schett, Georg, Spiera, Robert, Unizony, Sebastian H., Collinson, Neil

    出版 2019
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  7. 7
    Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics

    Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics 由 Dennis, Glynn, Holweg, Cécile TJ, Kummerfeld, Sarah K, Choy, David F, Setiadi, A Francesca, Hackney, Jason A, Haverty, Peter M, Gilbert, Houston, Lin, Wei Yu, Diehl, Lauri, Fischer, S, Song, An, Musselman, David, Klearman, Micki, Gabay, Cem, Kavanaugh, Arthur, Endres, Judith, Fox, David A, Martin, Flavius, Townsend, Michael J

    出版 2014
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:

检索工具: